martes, 20 de septiembre de 2022

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial | Nature Communications

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial | Nature Communications

No hay comentarios:

Publicar un comentario